DUXB
gene geneOn this page
Summary
DUXB (double homeobox B, HGNC:33345) is a protein-coding gene on chromosome 16q23.1, encoding Double homeobox protein B (A0A1W2PPF3).
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleoplasm. Predicted to be active in nucleus.
Source: NCBI Gene 100033411 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 5 total
- MANE Select transcript:
NM_001351307
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33345 |
| Approved symbol | DUXB |
| Name | double homeobox B |
| Location | 16q23.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000282757 |
| Ensembl biotype | protein_coding |
| OMIM | 618698 |
| Entrez | 100033411 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000633875
RefSeq mRNA: 2 — MANE Select: NM_001351307
NM_001351307, NM_001351309
CCDS: CCDS86542
Canonical transcript exons
ENST00000633875 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003776065 | 75695961 | 75696115 |
| ENSE00003777418 | 75693893 | 75694525 |
| ENSE00003783668 | 75700015 | 75700169 |
| ENSE00003783937 | 75696838 | 75696943 |
| ENSE00003811083 | 75701394 | 75701461 |
Expression profiles
Bgee: expression breadth broad, 55 present calls, max score 63.11.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0564 / max 19.1172, expressed in 22 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 158185 | 0.0564 | 22 |
Top tissues by expression
90 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 63.11 | gold quality |
| corpus callosum | UBERON:0002336 | 58.16 | gold quality |
| sural nerve | UBERON:0015488 | 54.05 | silver quality |
| bone marrow cell | CL:0002092 | 47.67 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 46.40 | gold quality |
| colonic epithelium | UBERON:0000397 | 45.88 | silver quality |
| left lobe of thyroid gland | UBERON:0001120 | 45.19 | gold quality |
| thyroid gland | UBERON:0002046 | 45.12 | gold quality |
| blood | UBERON:0000178 | 44.95 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 44.66 | gold quality |
| right lung | UBERON:0002167 | 43.19 | silver quality |
| tonsil | UBERON:0002372 | 42.78 | gold quality |
| apex of heart | UBERON:0002098 | 41.42 | silver quality |
| lower esophagus mucosa | UBERON:0035834 | 40.95 | silver quality |
| muscle tissue | UBERON:0002385 | 40.57 | gold quality |
| kidney | UBERON:0002113 | 40.28 | silver quality |
| vagina | UBERON:0000996 | 39.95 | silver quality |
| uterine cervix | UBERON:0000002 | 39.74 | silver quality |
| tibial nerve | UBERON:0001323 | 39.55 | silver quality |
| monocyte | CL:0000576 | 39.25 | silver quality |
| ovary | UBERON:0000992 | 39.02 | silver quality |
| muscle of leg | UBERON:0001383 | 38.97 | silver quality |
| right ovary | UBERON:0002118 | 38.87 | silver quality |
| left ovary | UBERON:0002119 | 38.60 | silver quality |
| gastrocnemius | UBERON:0001388 | 38.38 | silver quality |
| leukocyte | CL:0000738 | 38.20 | silver quality |
| skin of leg | UBERON:0001511 | 37.95 | silver quality |
| endometrium | UBERON:0001295 | 37.80 | gold quality |
| spleen | UBERON:0002106 | 37.62 | silver quality |
| ectocervix | UBERON:0012249 | 37.18 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.45 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (50): ARX (ENSG00000004848), PAX6 (ENSG00000007372), PAX7 (ENSG00000009709), ALX4 (ENSG00000052850), GSC2 (ENSG00000063515), PITX1 (ENSG00000069011), PAX2 (ENSG00000075891), RHOXF1 (ENSG00000101883), CRX (ENSG00000105392), EVX1 (ENSG00000106038), PAX4 (ENSG00000106331), NOBOX (ENSG00000106410), PITX3 (ENSG00000107859), PHOX2B (ENSG00000109132), OTX1 (ENSG00000115507), PRRX1 (ENSG00000116132), VSX2 (ENSG00000119614), ESX1 (ENSG00000123576), PAX8 (ENSG00000125618), PAX1 (ENSG00000125813), RHOXF2 (ENSG00000131721), GSC (ENSG00000133937), RAX (ENSG00000134438), PAX3 (ENSG00000135903), ALX3 (ENSG00000156150), HESX1 (ENSG00000163666), PITX2 (ENSG00000164093), UNCX (ENSG00000164853), PHOX2A (ENSG00000165462), OTX2 (ENSG00000165588), DRGX (ENSG00000165606), PRRX2 (ENSG00000167157), SHOX2 (ENSG00000168779), OTP (ENSG00000171540), RAX2 (ENSG00000173976), EVX2 (ENSG00000174279), PROP1 (ENSG00000175325), ISX (ENSG00000175329), ALX1 (ENSG00000180318), MIXL1 (ENSG00000185155)
Protein
Protein identifiers
Double homeobox protein B — A0A1W2PPF3 (reviewed: A0A1W2PPF3)
All UniProt accessions (1): A0A1W2PPF3
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
Similarity. Belongs to the paired homeobox family.
RefSeq proteins (2): NP_001338236, NP_001338238 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR017970 | Homeobox_CS | Conserved_site |
| IPR051306 | Homeobox_regulator | Family |
Pfam: PF00046
UniProt features (8 total): sequence conflict 3, DNA-binding region 2, chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1W2PPF3-F1 | 58.91 | 0.22 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9819196 | Zygotic genome activation (ZGA) |
MSigDB gene sets: 8 (showing top):
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, chr16q23, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT, REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA, GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (3): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677)
GO Cellular Component (2): nucleus (GO:0005634), nucleoplasm (GO:0005654)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Maternal to zygotic transition (MZT) | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
306 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DUXB | DPRX | A6NFQ7 | 808 |
| DUXB | TPRX1 | Q8N7U7 | 768 |
| DUXB | ARGFX | A6NJG6 | 730 |
| DUXB | LEUTX | A8MZ59 | 727 |
| DUXB | NANOGNB | Q7Z5D8 | 609 |
| DUXB | PLAC9 | Q5JTB6 | 608 |
| DUXB | ADAT1 | Q9BUB4 | 561 |
| DUXB | HESX1 | Q9UBX0 | 529 |
| DUXB | ANHX | E9PGG2 | 513 |
| DUXB | MBD3L3 | A6NE82 | 503 |
| DUXB | RHOXF2B | P0C7M4 | 490 |
| DUXB | MBD3L5 | A6NJ08 | 471 |
| DUXB | MBD3L2 | Q8NHZ7 | 471 |
| DUXB | TERF2IP | Q9NYB0 | 460 |
| DUXB | ZSCAN4 | Q8NAM6 | 451 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1W2PPF3, A0A1W2PPM1, A1A546, A1YGI6, A2T763, A5YC49, A6NFQ7, A6NJG6, D2HQI1, G3X9P6, O42173, O57374, P09632, P0C7M4, P10242, P14837, P17278, P31272, P31538, Q1KKS8, Q28ET4, Q28G02, Q3LTE0, Q3UT54, Q4JM65, Q4KL20, Q5TM83, Q5TM84, Q5W1J6, Q68EH7, Q6NSW7, Q80Z64, Q8IUE1, Q8JH55, Q8JIT7, Q8JJ26, Q8MIB7, Q8MIB8, Q8MIE9, Q91685
Diamond homologs: A0A1W2PPF3, A1YEY5, A1YFI3, A1YG57, A2T733, A2T7P4, A6NLW8, A6NNA5, F1NEA7, G5EBU4, G5EDS1, O18381, O35137, O35160, O42250, O43186, O43316, O43812, O54751, O70137, O73917, O75360, O75364, O95076, P09088, P0CJ85, P0CJ86, P0CJ87, P0CJ88, P0CJ89, P0CJ90, P21711, P22810, P26367, P26630, P29454, P32242, P32243, P34764, P34765
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
5 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 4 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
232 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:75694523:CAT:C | acceptor_gain | 0.9900 |
| 16:75695959:A:AC | donor_gain | 0.9900 |
| 16:75695960:C:CC | donor_gain | 0.9900 |
| 16:75696112:TATT:T | acceptor_gain | 0.9900 |
| 16:75696114:TT:T | acceptor_gain | 0.9900 |
| 16:75696116:C:CC | acceptor_gain | 0.9900 |
| 16:75700009:GCCTA:G | donor_loss | 0.9900 |
| 16:75700010:CCTAC:C | donor_loss | 0.9900 |
| 16:75700011:CTA:C | donor_loss | 0.9900 |
| 16:75700013:ACCT:A | donor_loss | 0.9900 |
| 16:75700014:C:CA | donor_loss | 0.9900 |
| 16:75694521:CACAT:C | acceptor_gain | 0.9800 |
| 16:75694526:C:CC | acceptor_gain | 0.9800 |
| 16:75696115:TC:T | acceptor_loss | 0.9800 |
| 16:75696116:C:CA | acceptor_loss | 0.9800 |
| 16:75696117:T:G | acceptor_loss | 0.9800 |
| 16:75694524:ATC:A | acceptor_loss | 0.9700 |
| 16:75694525:TC:T | acceptor_loss | 0.9700 |
| 16:75694526:C:A | acceptor_loss | 0.9700 |
| 16:75695954:AACTT:A | donor_loss | 0.9700 |
| 16:75695955:ACTTA:A | donor_loss | 0.9700 |
| 16:75695956:CT:C | donor_loss | 0.9700 |
| 16:75695957:TTA:T | donor_loss | 0.9700 |
| 16:75695958:TACTT:T | donor_loss | 0.9700 |
| 16:75696111:GTATT:G | acceptor_gain | 0.9700 |
| 16:75696942:ACCTA:A | acceptor_loss | 0.9500 |
| 16:75696943:CCT:C | acceptor_loss | 0.9500 |
| 16:75695953:GAACT:G | donor_loss | 0.9400 |
| 16:75696939:CAAAC:C | acceptor_gain | 0.9300 |
| 16:75694522:ACATC:A | acceptor_gain | 0.9200 |
AlphaMissense
2299 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:75696935:A:C | F63L | 0.992 |
| 16:75696935:A:T | F63L | 0.992 |
| 16:75696937:A:G | F63L | 0.992 |
| 16:75694517:A:C | F150L | 0.990 |
| 16:75694517:A:T | F150L | 0.990 |
| 16:75694519:A:G | F150L | 0.990 |
| 16:75700093:A:C | F34L | 0.985 |
| 16:75700093:A:T | F34L | 0.985 |
| 16:75700095:A:G | F34L | 0.985 |
| 16:75700050:C:G | A49P | 0.983 |
| 16:75700106:A:T | L30H | 0.981 |
| 16:75696936:A:G | F63S | 0.980 |
| 16:75700049:G:T | A49D | 0.978 |
| 16:75700106:A:G | L30P | 0.974 |
| 16:75696940:A:G | W62R | 0.973 |
| 16:75696940:A:T | W62R | 0.973 |
| 16:75696039:A:C | F121L | 0.971 |
| 16:75696039:A:T | F121L | 0.971 |
| 16:75696041:A:G | F121L | 0.971 |
| 16:75700117:T:A | Q26H | 0.970 |
| 16:75700117:T:G | Q26H | 0.970 |
| 16:75700052:A:G | L48P | 0.968 |
| 16:75700060:T:A | R45S | 0.968 |
| 16:75700060:T:G | R45S | 0.968 |
| 16:75695996:C:G | A136P | 0.963 |
| 16:75694518:A:G | F150S | 0.961 |
| 16:75700049:G:A | A49V | 0.961 |
| 16:75696923:T:A | R67S | 0.955 |
| 16:75696923:T:G | R67S | 0.955 |
| 16:75700094:A:G | F34S | 0.954 |
dbSNP variants (sampled 300 via entrez): RS1000071723 (16:75700275 C>T), RS1000153072 (16:75700665 C>A,T), RS1000274471 (16:75700828 T>G), RS1000292185 (16:75697904 G>A,T), RS1000873441 (16:75699745 T>G), RS1000929917 (16:75694367 G>A,C), RS1001556514 (16:75699568 T>C), RS1002004937 (16:75703121 G>A), RS1002018632 (16:75696617 T>C,G), RS1002116340 (16:75701772 G>A), RS1002178652 (16:75701501 G>A,C), RS1002279638 (16:75698491 A>G), RS1002369433 (16:75696864 T>C), RS1002634837 (16:75694203 A>C,G), RS1002881335 (16:75697234 C>G,T)
Disease associations
OMIM: gene MIM:618698 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
1 total (human), top 1 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| abrine | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.